Phenyl quinolines and their use as estrogenic agents
申请人:Vu Thien An
公开号:US20050009784A1
公开(公告)日:2005-01-13
This invention provides estrogen receptor modulators of formula I, having the structure
wherein,
R
1
, R
2
, R
3
, R
4
, R
5
, and R
6
are as defined in the specification, or a N-oxide thereof or a pharmaceutically acceptable salt thereof or a prodrug thereof.
ERβ ligands. Part 4: Synthesis and structure–activity relationships of a series of 2-phenylquinoline derivatives
作者:An T. Vu、Stephen T. Cohn、Eric S. Manas、Heather A. Harris、Richard E. Mewshaw
DOI:10.1016/j.bmcl.2005.07.008
日期:2005.10
A new class of estrogen receptor beta (ERbeta) ligands based on the 2-phenylquinoline scaffold was prepared. Several analogues with C4 substitution displayed high affinity (3-5 nM) and significant selectivity (up to 83-fold) for ERbeta. The best compound, 13b, was profiled as a selective partial agonist for ERbeta at 1 muM in a cell-based transcriptional assay. Uterine weight bioassay of 13b indicated
Fluorous <scp>l</scp>-Carbidopa Precursors: Highly Enantioselective Synthesis and Computational Prediction of Bioactivity
作者:Albert Granados、Anna del Olmo、Francesca Peccati、Thierry Billard、Mariona Sodupe、Adelina Vallribera
DOI:10.1021/acs.joc.7b02685
日期:2018.1.5
(S)-α-aminated β-keto esters were prepared through a highly enantioselectiveelectrophilic α-amination step in the presence of europium triflate and (R,R)-phenyl-pybox. These compounds are precursors of fluorinated analogues of l-carbidopa, which is known to inhibit DOPA decarboxylase (DDC), a key protein in Parkinson’s disease. Fluorination provides better stability for biological applications, which